Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
7 "Meta-analysis"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Article image
Analysis of PAX8 immunohistochemistry in lung cancers: a meta-analysis
Jae Han Jeong, Nae Yu Kim, Jung-Soo Pyo
J Pathol Transl Med. 2020;54(4):300-309.   Published online July 10, 2020
DOI: https://doi.org/10.4132/jptm.2020.06.08
  • 4,640 View
  • 136 Download
  • 8 Web of Science
  • 6 Crossref
AbstractAbstract PDF
Background
In this meta-analysis, we aimed to evaluate the PAX8 immunohistochemical expressions in primary lung cancers and metastatic cancers to the lung.
Methods
We identified and reviewed relevant articles from the PubMed databases. Ultimately, 18 articles were included in this meta-analysis. PAX8 expression rates were analyzed and compared between primary and metastatic lung cancers.
Results
The PAX8 expression rate in primary lung cancers was 0.042 (95% confidence interval [CI], 0.025 to 0.071). PAX8 expression rates of small cell (0.129; 95% CI, 0.022 to 0.496) and non-small cell carcinomas of the lung (0.037; 95% CI, 0.022 to 0.061) were significantly different (p=.049 in a meta-regression test). However, the PAX8 expression rates of adenocarcinoma (0.013; 95% CI, 0.006 to 0.031) and squamous cell carcinoma (0.040; 95% CI, 0.016 to 0.097) were not significantly different. PAX8 expression rates of metastatic carcinomas to the lung varied, ranging from 1.8% to 94.9%. Metastatic carcinomas from the lung to other organs had a PAX8 expression rate of 6.3%. The PAX8 expression rates of metastatic carcinomas from the female genital organs, kidneys, and thyroid gland to the lung were higher than those of other metastatic carcinomas.
Conclusions
Primary lung cancers had a low PAX8 expression rate regardless of tumor subtype. However, the PAX8 expression rates of metastatic carcinomas from the female genital organs, kidneys, and thyroid were significantly higher than those of primary lung cancers.

Citations

Citations to this article as recorded by  
  • Prognostic value of PAX8 in small cell lung cancer
    Fengyun Tao, Hangyan Zhu, Jiayun Xu, Yanan Guo, Xin Wang, Lei Shao, Deng Pan, Guosheng Li, Rong Fang
    Heliyon.2024; 10(7): e28251.     CrossRef
  • Cystic primary squamous cell carcinoma of the thyroid
    Sakurako Harada‐Kagitani, Yusuke Kouchi, Yoshiki Shinomiya, Takuto Hiramoto, Tomoyuki Arai, Toyoyuki Hanazawa, Kiyotaka Onodera, Kaito Nakama, Takanori Aihara, Masayuki Ota, Jun‐Ichiro Ikeda, Takashi Kishimoto
    Pathology International.2024; 74(5): 292.     CrossRef
  • The combination of p16 and Rb expression pattern is helpful to predict high-risk HPV infection and the primary site in lymph node metastases of squamous cell carcinoma
    Ryosuke Kuga, Hidetaka Yamamoto, Fumiya Narutomi, Misa Suzuki, Rina Jiromaru, Takahiro Hongo, Kazuhisa Hachisuga, Nobuko Yasutake, Kiyoko Kato, Takashi Nakagawa, Yoshinao Oda
    Pathology - Research and Practice.2024; 263: 155642.     CrossRef
  • Mesonephric adenocarcinoma of the uterine cervix with a prominent spindle cell component
    Yingying Fan, Ying He, Liang Sun, Tianmin Liu, Yangmei Shen
    Oncology Letters.2024;[Epub]     CrossRef
  • Immunocytochemistry of effusions: Processing and commonly used immunomarkers
    Vinod B. Shidham, Beata Janikowski
    Cytojournal.2022; 19: 6.     CrossRef
  • Significance analysis of PAX8 expression in endometrial carcinoma
    Shan Hu, Hua Gan, Fengmei Yang
    Medicine.2022; 101(42): e31159.     CrossRef
Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
Jung-Soo Pyo, Nae Yu Kim, Won Jin Cho
J Pathol Transl Med. 2019;53(3):173-179.   Published online March 5, 2019
DOI: https://doi.org/10.4132/jptm.2019.02.03
  • 6,308 View
  • 165 Download
  • 6 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Background
Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin- 1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis.
Methods
The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted.
Results
Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS.
Conclusions
Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.

Citations

Citations to this article as recorded by  
  • Expression and Targeted Application of Claudins Family in Hepatobiliary and Pancreatic Diseases
    Fangqian Du, Yuwei Xie, Shengze Wu, Mengling Ji, Bingzi Dong, Chengzhan Zhu
    Journal of Hepatocellular Carcinoma.2024; Volume 11: 1801.     CrossRef
  • The Significance of Relative Claudin Expression in Odontogenic Tumors
    Ekarat Phattarataratip, Kraisorn Sappayatosok
    Head and Neck Pathology.2020; 14(2): 480.     CrossRef
  • Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer
    Simon Kind, Franziska Büscheck, Doris Höflmayer, Claudia Hube-Magg, Martina Kluth, Maria Christina Tsourlakis, Stefan Steurer, Till S. Clauditz, Andreas M. Luebke, Eike Burandt, Waldemar Wilczak, Andrea Hinsch, David Dum, Sören Weidemann, Christoph Fraune
    World Journal of Urology.2020; 38(9): 2185.     CrossRef
  • Characterisation of endogenous Claudin‐1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock‐in cells
    Camille M.H. Clément, Maika S. Deffieu, Cristina M. Dorobantu, Thomas F. Baumert, Nilda Vanesa Ayala‐Nunez, Yves Mély, Philippe Ronde, Raphael Gaudin
    Biology of the Cell.2020; 112(5): 140.     CrossRef
  • Comment on “Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis”
    Bolin Wang, Yan Huang
    Journal of Pathology and Translational Medicine.2019; 53(6): 411.     CrossRef
Prognostic Role of Metastatic Lymph Node Ratio in Papillary Thyroid Carcinoma
Jung-Soo Pyo, Jin Hee Sohn, Kyungseek Chang
J Pathol Transl Med. 2018;52(5):331-338.   Published online August 30, 2018
DOI: https://doi.org/10.4132/jptm.2018.08.07
  • 6,649 View
  • 127 Download
  • 13 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Background
The aim of this study is to elucidate the clinicopathological significances, including the prognostic role, of metastatic lymph node ratio (mLNR) and tumor deposit diameter in papillary thyroid carcinoma (PTC) through a retrospective review and meta-analysis.
Methods
We categorized the cases into high (≥ 0.44) and low mLNR (< 0.44) and investigated the correlations with clinicopathological parameters in 64 PTCs with neck level VI lymph node (LN) metastasis. In addition, meta-analysis of seven eligible studies was used to investigate the correlation between mLNR and survival.
Results
Among 64 PTCs with neck level VI LN metastasis, high mLNR was found in 34 PTCs (53.1%). High mLNR was significantly correlated with macrometastasis (tumor deposit diameter ≥ 0.2 cm), extracapsular spread, and number of metastatic LNs. Based on linear regression test, mLNR was significantly increased by the largest LN size but not the largest metastatic LN (mLN) size. High mLNR was not correlated with nuclear factor κB or cyclin D1 immunohistochemical expression, Ki-67 labeling index, or other pathological parameters of primary tumor. Based on meta-analysis, high mLNR significantly correlated with worse disease-free survival at the 5-year and 10-year follow-up (hazard ratio [HR], 4.866; 95% confidence interval [CI], 3.527 to 6.714 and HR, 5.769; 95% CI, 2.951 to 11.275, respectively).
Conclusions
Our data showed that high mLNR significantly correlated with worse survival, macrometastasis, and extracapsular spread of mLNs. Further cumulative studies for more detailed criteria of mLNR are needed before application in daily practice.

Citations

Citations to this article as recorded by  
  • Application and subgroup analysis of competing risks model based on different lymph node staging systems in differentiated thyroid cancer
    Zhe Xu Cao, Jiang Sheng Huang, Ming Ming Wang
    Updates in Surgery.2024; 76(5): 1927.     CrossRef
  • Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
    Helene Lindfors, Marie Karlsen, Ellinor Karlton, Jan Zedenius, Catharina Larsson, Catharina Ihre Lundgren, C. Christofer Juhlin, Ivan Shabo
    Scientific Reports.2023;[Epub]     CrossRef
  • Incidental Node Metastasis as an Independent Factor of Worse Disease-Free Survival in Patients with Papillary Thyroid Carcinoma
    Renan Aguera Pinheiro, Ana Kober Leite, Beatriz Godoi Cavalheiro, Evandro Sobroza de Mello, Luiz Paulo Kowalski, Leandro Luongo Matos
    Cancers.2023; 15(3): 943.     CrossRef
  • A High-Quality Nomogram for Predicting Lung Metastasis in Newly Diagnosed Stage IV Thyroid Cancer: A Population-Based Study
    WenYi Wang, JiaJing Liu, XiaoFan Xu, LiQun Huo, XuLin Wang, Jun Gu
    Technology in Cancer Research & Treatment.2023;[Epub]     CrossRef
  • Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield
    Il Ku Kang, Joonseon Park, Ja Seong Bae, Jeong Soo Kim, Kwangsoon Kim
    Cancers.2023; 15(11): 2947.     CrossRef
  • Superiority of metastatic lymph node ratio over number of node metastases and TNM/AJCC N classification in predicting cancer‐specific survival in medullary thyroid cancer
    Andreas Machens, Kerstin Lorenz, Frank Weber, Henning Dralle
    Head & Neck.2022; 44(12): 2717.     CrossRef
  • Value of Combining Clinical Factors, Conventional Ultrasound, and Contrast-Enhanced Ultrasound Features in Preoperative Prediction of Central Lymph Node Metastases of Different Sized Papillary Thyroid Carcinomas
    Yanfang Wang, Fang Nie, Guojuan Wang, Ting Liu, Tiantian Dong, Yamin Sun
    Cancer Management and Research.2021; Volume 13: 3403.     CrossRef
  • Atypical Histiocytoid Cells and Multinucleated Giant Cells in Fine-Needle Aspiration Cytology of the Thyroid Predict Lymph Node Metastasis of Papillary Thyroid Carcinoma
    Ji Eun Choi, Ja Seong Bae, Dong-Jun Lim, So Lyung Jung, Chan Kwon Jung
    Cancers.2019; 11(6): 816.     CrossRef
  • Patients Aged ≥55 Years With Stage T1-2N1M1 Differentiated Thyroid Cancer Should Be Downstaged in the Eighth Edition AJCC/TNM Cancer Staging System
    Zeming Liu, Sichao Chen, Yihui Huang, Di Hu, Min Wang, Wei Wei, Chao Zhang, Wen Zeng, Liang Guo
    Frontiers in Oncology.2019;[Epub]     CrossRef
  • Prognostic Implication of Metastatic Lymph Node Ratio in Colorectal Cancers: Comparison Depending on Tumor Location
    Jung-Soo Pyo, Young-Min Shin, Dong-Wook Kang
    Journal of Clinical Medicine.2019; 8(11): 1812.     CrossRef
Review
Thyroid Cytology in India: Contemporary Review and Meta-analysis
Shipra Agarwal, Deepali Jain
J Pathol Transl Med. 2017;51(6):533-547.   Published online October 5, 2017
DOI: https://doi.org/10.4132/jptm.2017.08.04
  • 9,403 View
  • 206 Download
  • 14 Web of Science
  • 16 Crossref
AbstractAbstract PDF
Fine-needle aspiration cytology (FNAC) is a screening test for triaging thyroid nodules, aiding in subsequent clinical management. However, the advantages have been overshadowed by the multiplicity of reporting systems and a wide range of nomenclature used. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) was formulated in 2007, to give the world a uniform thyroid cytology reporting system, facilitating easy interpretation by the clinicians. Here, we review the status of thyroid FNAC in India in terms of various reporting systems used including a meta-analysis of the previously published data. An extensive literature search was performed using internet search engines. The reports with detailed classification system used in thyroid cytology were included. The meta-analysis of published data was compared with the implied risk of malignancy by TBSRTC. More than 50 studies were retrieved and evaluated. TBSRTC is currently the most widely used reporting system with different studies showing good efficacy and interobserver concordance. Ancillary techniques have, as of now, limited applicability and acceptability in thyroid cytology in India. Twenty-eight published articles met the criteria for inclusion in the meta-analysis. When compared with TBSRTC recommendations, the meta-analysis showed a higher risk of malignancy for categories I and III. Thyroid FNAC is practiced all over India. TBSRTC has found widespread acceptance, with most institutions using this system for routine thyroid cytology reporting. However, reasons for a high malignancy risk for categories I and III need to be looked into. Various possible contributing factors are discussed in the review.

Citations

Citations to this article as recorded by  
  • Thermal imaging based pre-diagnostics tool for Graves’ disease
    Vaishali Sharma, Vandana K Dhingra, Snehlata Shakya, Ashok Kumar, Mayank Goswami
    Measurement Science and Technology.2024; 35(3): 035702.     CrossRef
  • High Malignancy Risk and Its Predictors in South Indian Patients With Bethesda II Thyroid Nodules
    Sunanda Tirupati, Pradeep Puthenveetil, Shilpa Lakkundi, Anudeep Gaddam, Vijaya Sarathi
    Cureus.2024;[Epub]     CrossRef
  • Nuclear features in thyroid cytology: features helpful for a morphological diagnosis in routine practice
    Priya Bhagwat, Sabine Pomplun
    Diagnostic Histopathology.2024; 30(6): 312.     CrossRef
  • Evaluation of Thyroid Lesions by the Bethesda System for Reporting Thyroid Cytopathology
    Syed Asif Hashmi, Monika Aggrawal, Rahul Pandey, Deepika Gulati, Inam Danish Khan
    Journal of Marine Medical Society.2023; 25(1): 73.     CrossRef
  • Incidence and Malignancy Rates in Thyroid Nodules in North-East Indian Population by Bethesda System: A Single Institutional Experience of 3 Years
    Suvamoy Chakraborty, Manu C. Balakrishnan, Vandana Raphael, Prachurya Tamuli, Anuradha Deka
    South Asian Journal of Cancer.2023; 12(02): 166.     CrossRef
  • Evaluation of Concordance of Ultrasound, Cytology, and Histopathology in Solitary Thyroid Nodules
    Sunil Chumber, Surabhi Vyas, Kamal Kataria, Shipra Agarwal, Yashwant S Rathore, Gopal Puri, Sushma Yadav, Kanika Sharma, Amit Patidar
    Indian Journal of Endocrine Surgery and Research.2023; 18(1): 17.     CrossRef
  • Cytomorphological Spectrum of Head and Neck Lesions by Fine Needle Aspiration Cytology in a Tertiary Care Center
    Amandeep Kaur, Sonali Poonia, Karandeep Singh, Dalbir Kaur, Mohit Madhukar, Ravish Godara
    Journal of Pharmacy and Bioallied Sciences.2023; 15(Suppl 1): S315.     CrossRef
  • The Asian Thyroid Working Group, from 2017 to 2023
    Kennichi Kakudo, Chan Kwon Jung, Zhiyan Liu, Mitsuyoshi Hirokawa, Andrey Bychkov, Huy Gia Vuong, Somboon Keelawat, Radhika Srinivasan, Jen-Fan Hang, Chiung-Ru Lai
    Journal of Pathology and Translational Medicine.2023; 57(6): 289.     CrossRef
  • Cytomorphological Categorization of Thyroid Lesions according to The Bethesda System for Reporting Thyroid Cytology and Correlation with their Histological Outcome
    Meenakshi Kamboj, Anurag Mehta, Sunil Pasricha, Gurudutt Gupta, Anila Sharma, Garima Durga
    Journal of Cytology.2022; 39(1): 44.     CrossRef
  • Is Surgery Necessary in Benign Thyroid Lesions?
    Pushkar Chaudhary, Naseem Noorunnisa
    Journal of Datta Meghe Institute of Medical Sciences University.2022; 17(3): 799.     CrossRef
  • Effect of the Noninvasive Follicular Thyroid Neoplasm With Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision on Indian Thyroid Fine-Needle Aspiration Practice
    Chanchal Rana, Pooja Ramakant, Divya Goel, Akanksha Singh, KulRanjan Singh, Suresh Babu, Anand Mishra
    American Journal of Clinical Pathology.2021; 156(2): 320.     CrossRef
  • The combination of ACR‐Thyroid Imaging Reporting and Data system and The Bethesda System for Reporting Thyroid Cytopathology in the evaluation of thyroid nodules—An institutional experience
    Shanmugasundaram Sakthisankari, Sreenivasan Vidhyalakshmi, Sivanandam Shanthakumari, Balalakshmoji Devanand, Udayasankar Nagul
    Cytopathology.2021; 32(4): 472.     CrossRef
  • Differentiated Thyroid Cancer
    Anita M. Borges
    Journal of Head & Neck Physicians and Surgeons.2021; 9(2): 69.     CrossRef
  • Risk of malignancy in Thyroid “Atypia of undetermined significance/Follicular lesion of undetermined significance” and its subcategories – A 5-year experience
    Abha Thakur, Haimanti Sarin, Dilpreet Kaur, Deepak Sarin
    Indian Journal of Pathology and Microbiology.2019; 62(4): 544.     CrossRef
  • Thyroid FNA cytology in Asian practice—Active surveillance for indeterminate thyroid nodules reduces overtreatment of thyroid carcinomas
    K. Kakudo, M. Higuchi, M. Hirokawa, S. Satoh, C. K. Jung, A. Bychkov
    Cytopathology.2017; 28(6): 455.     CrossRef
  • The Use of Fine-Needle Aspiration (FNA) Cytology in Patients with Thyroid Nodules in Asia: A Brief Overview of Studies from the Working Group of Asian Thyroid FNA Cytology
    Chan Kwon Jung, SoonWon Hong, Andrey Bychkov, Kennichi Kakudo
    Journal of Pathology and Translational Medicine.2017; 51(6): 571.     CrossRef
Original Articles
Detection of Human Papillomavirus in Korean Breast Cancer Patients by Real-Time Polymerase Chain Reaction and Meta-Analysis of Human Papillomavirus and Breast Cancer
Jinhyuk Choi, Chungyeul Kim, Hye Seung Lee, Yoo Jin Choi, Ha Yeon Kim, Jinhwan Lee, Hyeyoon Chang, Aeree Kim
J Pathol Transl Med. 2016;50(6):442-450.   Published online October 10, 2016
DOI: https://doi.org/10.4132/jptm.2016.07.08
  • 11,731 View
  • 221 Download
  • 14 Web of Science
  • 15 Crossref
AbstractAbstract PDF
Background
Human papillomavirus (HPV) is a well-established oncogenic virus of cervical, anogenital, and oropharyngeal cancer. Various subtypes of HPV have been detected in 0% to 60% of breast cancers. The roles of HPV in the carcinogenesis of breast cancer remain controversial. This study was performed to determine the prevalence of HPV-positive breast cancer in Korean patients and to evaluate the possibility of carcinogenic effect of HPV on breast.
Methods
Meta-analysis was performed in 22 case-control studies for HPV infection in breast cancer. A total of 123 breast cancers, nine intraductal papillomas and 13 nipple tissues of patients with proven cervical HPV infection were tested by real-time polymerase chain reaction to detect 28 subtypes of HPV. Breast cancers were composed of 106 formalin-fixed and paraffin embedded (FFPE) breast cancer samples and 17 touch imprint cytology samples of breast cancers.
Results
The overall odds ratio between breast cancer and HPV infection was 5.43 (95% confidence interval, 3.24 to 9.12) with I2 = 34.5% in meta-analysis of published studies with case-control setting and it was statistically significant. HPV was detected in 22 cases of breast cancers (17.9%) and two cases of intaductal papillomas (22.2%). However, these cases had weak positivity.
Conclusions
These results failed to serve as significant evidence to support the relationship between HPV and breast cancer. Further study with larger epidemiologic population is merited to determine the relationship between HPV and breast cancer.

Citations

Citations to this article as recorded by  
  • Bacterial-Viral Interactions in Human Orodigestive and Female Genital Tract Cancers: A Summary of Epidemiologic and Laboratory Evidence
    Ikuko Kato, Jilei Zhang, Jun Sun
    Cancers.2022; 14(2): 425.     CrossRef
  • Breast cancer association with oncogenic papillomaviruses: papillomaviral DNA detection in breast cancer cells
    G. M. Volgareva
    Advances in Molecular Oncology.2022; 9(2): 10.     CrossRef
  • Presence of Human Papillomavirus DNA in Malignant Neoplasia and Non-Malignant Breast Disease
    Erika Maldonado-Rodríguez, Marisa Hernández-Barrales, Adrián Reyes-López, Susana Godina-González, Perla I. Gallegos-Flores, Edgar L. Esparza-Ibarra, Irma E. González-Curiel, Jesús Aguayo-Rojas, Adrián López-Saucedo, Gretel Mendoza-Almanza, Jorge L. Ayala-
    Current Issues in Molecular Biology.2022; 44(8): 3648.     CrossRef
  • Risk Role of Breast Cancer in Association with Human Papilloma Virus among Female Population in Taiwan: A Nationwide Population-Based Cohort Study
    Chia-Hsin Liu, Chi-You Liao, Ming-Hsin Yeh, James Cheng-Chung Wei
    Healthcare.2022; 10(11): 2235.     CrossRef
  • HPV-Associated Breast Cancer: Myth or Fact?
    Erik Kudela, Eva Kudelova, Erik Kozubík, Tomas Rokos, Terezia Pribulova, Veronika Holubekova, Kamil Biringer
    Pathogens.2022; 11(12): 1510.     CrossRef
  • Assessment of Human Papillomavirus Infection and Risk Factors in Egyptian Women With Breast Cancer
    Nabila El-Sheikh, Nahla O Mousa, Amany M Tawfeik, Alaa M Saleh, Iman Elshikh, Mohamed Deyab, Faten Ragheb, Manar M Moneer, Ahmed Kawashti, Ahmed Osman, Mohamed Elrefaei
    Breast Cancer: Basic and Clinical Research.2021;[Epub]     CrossRef
  • Human Papillomavirus (HPV) Detection by Chromogenic In Situ Hybridization (CISH) and p16 Immunohistochemistry (IHC) in Breast Intraductal Papilloma and Breast Carcinoma
    Hua Guo, Juan P. Idrovo, Jin Cao, Sudarshana Roychoudhury, Pooja Navale, Louis J. Auguste, Tawfiqul Bhuiya, Silvat Sheikh-Fayyaz
    Clinical Breast Cancer.2021; 21(6): e638.     CrossRef
  • Human Papillomavirus in Breast Carcinogenesis: A Passenger, a Cofactor, or a Causal Agent?
    Rancés Blanco, Diego Carrillo-Beltrán, Juan P. Muñoz, Alejandro H. Corvalán, Gloria M. Calaf, Francisco Aguayo
    Biology.2021; 10(8): 804.     CrossRef
  • Systematic review and meta-analysis of the papillomavirus prevalence in breast cancer fresh tissues
    Geilson Gomes de Oliveira, Ana Katherine Gonçalves, José Eleutério, Luiz Gonzaga Porto Pinheiro
    Breast Disease.2021; 41(1): 123.     CrossRef
  • Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge?
    Fatih Levent Balci, Cihan Uras, Sheldon Marc Feldman
    Cancer Treatment and Research Communications.2019; 19: 100122.     CrossRef
  • Is the HPV virus responsible for the development of breast cancer?
    Erik Kudela, Marcela Nachajova, Jan Danko
    The Breast Journal.2019; 25(5): 1053.     CrossRef
  • Absence of Human Papillomavirus in Benign and Malignant Breast Tissue
    Maryam Kazemi Aghdam, Seyed Alireza Nadji, Azadeh Alvandimanesh, Maliheh Khoddami, Yassaman Khademi
    Iranian Journal of Pathology.2019; 14(4): 279.     CrossRef
  • Oncogenic Viruses and Breast Cancer: Mouse Mammary Tumor Virus (MMTV), Bovine Leukemia Virus (BLV), Human Papilloma Virus (HPV), and Epstein–Barr Virus (EBV)
    James S. Lawson, Brian Salmons, Wendy K. Glenn
    Frontiers in Oncology.2018;[Epub]     CrossRef
  • Viral infections and breast cancer – A current perspective
    O.M. Gannon, A. Antonsson, I.C. Bennett, N.A. Saunders
    Cancer Letters.2018; 420: 182.     CrossRef
  • Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer
    Wasifa Naushad, Orooj Surriya, Hajra Sadia
    Infection, Genetics and Evolution.2017; 54: 230.     CrossRef
Detection of Tumor Multifocality Is Important for Prediction of Tumor Recurrence in Papillary Thyroid Microcarcinoma: A Retrospective Study and Meta-Analysis
Jung-Soo Pyo, Jin Hee Sohn, Guhyun Kang
J Pathol Transl Med. 2016;50(4):278-286.   Published online June 6, 2016
DOI: https://doi.org/10.4132/jptm.2016.03.29
  • 9,877 View
  • 110 Download
  • 20 Web of Science
  • 22 Crossref
AbstractAbstract PDF
Background
The clinicopathological characteristics and conclusive treatment modality for multifocal papillary thyroid microcarcinoma (mPTMC) have not been fully established.
Methods
A retrospective study, systematic review, and meta-analysis were conducted to elucidate the clinicopathological significance of mPTMC. We investigated the multiplicity of 383 classical papillary thyroid microcarcinomas (PTMCs) and the clinicopathological significance of incidental mPTMCs. Correlation between tumor recurrence and multifocality in PTMCs was evaluated through a systematic review and meta-analysis.
Results
Tumor multifocality was identified in 103 of 383 PTMCs (26.9%). On linear regression analysis, primary tumor diameter was significantly correlated with tumor number (R2=0.014, p=.021) and supplemental tumor diameter (R2=0.117, p=.023). Of 103 mPTMCs, 61 (59.2%) were non-incidental, with tumor detected on preoperative ultrasonography, and 42 (40.8%) were diagnosed (incidental mPTMCs) on pathological examination. Lymph node metastasis and higher tumor stage were significantly correlated with tumor multifocality. However, there was no difference in nodal metastasis or tumor stage between incidental and non-incidental mPTMCs. On meta-analysis, tumor multifocality was significantly correlated with tumor recurrence in PTMCs (odds ratio, 2.002; 95% confidence interval, 1.475 to 2.719, p<.001).
Conclusions
Our results show that tumor multifocality in PTMC, regardless of manner of detection, is significantly correlated with aggressive tumor behavior.

Citations

Citations to this article as recorded by  
  • Retrospective comparison of individual risk factors hemithyroidectomy and thyroidectomy in patients with papillary carcinoma of the thyroid gland in combination with autoimmune thyroiditis
    E. V. Ryabchenko
    Head and Neck Tumors (HNT).2023; 12(4): 71.     CrossRef
  • Individual risk factors for recurrence after hemithyroidectomy and thyroidectomy in patients with papillary thyroid microcarcinoma in the presence of autoimmune thyroiditis
    E.V. Ryabchenko
    Onkologiya. Zhurnal imeni P.A.Gertsena.2023; 12(3): 20.     CrossRef
  • The value of total tumor diameter in unilateral multifocal papillary thyroid carcinoma: a propensity score matching analysis
    Zhu-juan Wu, Bao-ying Xia, Zi-wei Chen, Hao Gong, Munire Abuduwaili, Zhi-chao Xing, An-ping Su
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Negative Histopathological Prognostic Factors Affecting Morbidity in T1 Differentiated Thyroid Carcinoma
    Mine Araz, Elgin Özkan, Pınar Gunduz, Cigdem Soydal, N. Özlem Küçük, K. Metin Kır
    Cancer Biotherapy and Radiopharmaceuticals.2022; 37(1): 56.     CrossRef
  • Total tumor diameter is a better indicator of multifocal papillary thyroid microcarcinoma: A propensity score matching analysis
    Ke-cheng Jiang, Bei Lin, Yu Zhang, Ling-qian Zhao, Ding-cun Luo
    Frontiers in Endocrinology.2022;[Epub]     CrossRef
  • The relationship between lipotoxicity and risk of extrathyroidal extension in papillary thyroid microcarcinoma
    Changlin Li, Haixia Guan, Qiao He, Yishen Zhao, Nan liang, Jiao Zhang, Gianlorenzo Dionigi, Hui Sun
    Endocrine.2021; 74(3): 646.     CrossRef
  • Multifocality and Progression of Papillary Thyroid Microcarcinoma During Active Surveillance
    Ryuta Nagaoka, Aya Ebina, Kazuhisa Toda, Tomoo Jikuzono, Marie Saitou, Masaomi Sen, Hiroko Kazusaka, Mami Matsui, Keiko Yamada, Hiroki Mitani, Iwao Sugitani
    World Journal of Surgery.2021; 45(9): 2769.     CrossRef
  • Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
    Patrick D. Chin, Catherine Y. Zhu, Dipti P. Sajed, Gregory A. Fishbein, Michael W. Yeh, Angela M. Leung, Masha J. Livhits
    Endocrine Pathology.2020; 31(4): 377.     CrossRef
  • Application of Ultrasonography in the Diagnosis and Management of Papillary Thyroid Microcarcinoma
    Huang, MD Kun, Liu, MD Ji-Bin
    ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY.2020; 4(4): 284.     CrossRef
  • Analysis of Malignant Thyroid Neoplasms with a Striking Rise of Papillary Microcarcinoma in an Endemic Goiter Region
    Alka Mary Mathai, K. Preetha, S. Valsala Devi, Sam Vicliph, Raja Pradeep, Aqib Shaick
    Indian Journal of Otolaryngology and Head & Neck Surgery.2019; 71(S1): 121.     CrossRef
  • The first postoperative-stimulated serum thyroglobulin is a prognostic factor for thyroid microcarcinomas
    Isabela de Oliveira Amui, José Vicente Tagliarini, Emanuel C. Castilho, Mariângela de Alencar Marques, Yoshio Kiy, José Eduardo Corrente, Gláucia M.F.S. Mazeto
    Brazilian Journal of Otorhinolaryngology.2019; 85(1): 37.     CrossRef
  • Surgical management of follicular thyroid carcinoma in children and adolescents: A study of 30 cases
    Claudio Spinelli, Leonardo Rallo, Riccardo Morganti, Valentina Mazzotti, Alessandro Inserra, Giovanni Cecchetto, Maura Massimino, Paola Collini, Silvia Strambi
    Journal of Pediatric Surgery.2019; 54(3): 521.     CrossRef
  • The role of prophylactic central compartment lymph node dissection in elderly patients with differentiated thyroid cancer: a multicentric study
    Claudio Gambardella, Renato Patrone, Francesco Di Capua, Chiara Offi, Claudio Mauriello, Guglielmo Clarizia, Claudia Andretta, Andrea Polistena, Alessandro Sanguinetti, Pietrogiorgio Calò, Giovanni Docimo, Nicola Avenia, Giovanni Conzo
    BMC Surgery.2019;[Epub]     CrossRef
  • Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma, in the Central and Lateral Compartments, in Children and Adolescents: Predictive Factors
    C. Spinelli, F. Tognetti, S. Strambi, R. Morganti, M. Massimino, P. Collini
    World Journal of Surgery.2018; 42(8): 2444.     CrossRef
  • Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
    Shuai Xue, Peisong Wang, Zachary A. Hurst, Yi Seok Chang, Guang Chen
    Frontiers in Endocrinology.2018;[Epub]     CrossRef
  • A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study
    Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Suyeon Park, Mijin Kim, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Tae Yong Kim, Young Kee Shong, Won Bae Kim
    European Journal of Endocrinology.2017; 176(4): 371.     CrossRef
  • Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience
    Shuai Xue, Peisong Wang, Jia Liu, Guang Chen
    World Journal of Surgical Oncology.2017;[Epub]     CrossRef
  • Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting
    Hyemi Kwon, Min Ji Jeon, Won Gu Kim, Suyeon Park, Mijin Kim, Tae Yong Kim, Minkyu Han, Dong Eun Song, Tae-Yon Sung, Jong Ho Yoon, Suck Joon Hong, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
    Annals of Surgical Oncology.2017; 24(9): 2596.     CrossRef
  • Radioactive Iodine Ablation Decrease Recurrences in Papillary Thyroid Microcarcinoma with Lateral Lymph Node Metastasis in Chinese Patients
    Shuai Xue, Peisong Wang, Jia Liu, Guang Chen
    World Journal of Surgery.2017; 41(12): 3139.     CrossRef
  • The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer
    Fei Wang, Xiaolong Yu, Xiaopei Shen, Guangwu Zhu, Yueye Huang, Rengyun Liu, David Viola, Rossella Elisei, Efisio Puxeddu, Laura Fugazzola, Carla Colombo, Barbara Jarzab, Agnieszka Czarniecka, Alfred K Lam, Caterina Mian, Federica Vianello, Linwah Yip, Gar
    The Journal of Clinical Endocrinology & Metabolism.2017; 102(9): 3241.     CrossRef
  • Evaluation of surgical results of micropapillary thyroid cancers according to tumor size and focality
    Bekir Uçan, Muhammed Erkam Sencar, Muhammed Kızılgül, Mustafa Özbek, İlknur Öztürk Ünsal, Erman Çakal
    Ortadoğu Tıp Dergisi.2017; 9(3): 123.     CrossRef
  • Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients
    Kai Qian, Kai Guo, Xiaoke Zheng, Tuanqi Sun, Duanshu Li, Yi Wu, Qinghai Ji, Zhuoying Wang
    Oncotarget.2017; 8(39): 65836.     CrossRef
MUC2 Expression Is Correlated with Tumor Differentiation and Inhibits Tumor Invasion in Gastric Carcinomas: A Systematic Review and Meta-analysis
Jung-Soo Pyo, Jin Hee Sohn, Guhyun Kang, Dong-Hoon Kim, Kyungeun Kim, In-Gu Do, Dong Hyun Kim
J Pathol Transl Med. 2015;49(3):249-256.   Published online May 15, 2015
DOI: https://doi.org/10.4132/jptm.2015.03.27
  • 7,833 View
  • 68 Download
  • 5 Web of Science
  • 5 Crossref
AbstractAbstract PDF
Background
While MUC2 is expressed in intestinal metaplasia and malignant lesions, the clinico-pathological significance of MUC2 expression is not fully elucidated in gastric carcinoma (GC). Methods: The present study investigated the correlation between MUC2 expression and clinico-pathological parameters in 167 human GCs. In addition, to confirm the clinicopathological significance of MUC2 expression, we performed a systematic review and meta-analysis in 1,832 GCs. Results: MUC2 expression was found in 58 of 167 GCs (34.7%). MUC2-expressing GC showed lower primary tumor (T), regional lymph node (N), and tumor node metastasis (TNM) stages compared with GCs without MUC2 expression (p=.001, p=.001, and p=.011, respectively). However, MUC2 expression was not correlated with Lauren’s classification and tumor differentiation. In meta-analysis, MUC2 expression was significantly correlated with differentiation and lower tumor stage (odds ratio [OR], 1.303; 95% confidence interval [CI], 1.020 to 1.664; p = .034 and OR, 1.352; 95% CI, 1.055 to 1.734; p = .017, respectively) but not with Lauren’s classification, pN stage, or pTNM stage. Conclusions: MUC2 expression was correlated with a lower tumor depth and lower lymph node metastasis in our study; the meta-analysis showed a correlation of MUC2 expression with tumor differentiation and lower tumor depth.

Citations

Citations to this article as recorded by  
  • Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases
    Karina Malmros, Andreas Lindholm, Halla Vidarsdottir, Karin Jirström, Björn Nodin, Johan Botling, Johanna S. M. Mattsson, Patrick Micke, Maria Planck, Mats Jönsson, Johan Staaf, Hans Brunnström
    Virchows Archiv.2024; 485(2): 347.     CrossRef
  • Gastric epithelial histology and precancerous conditions
    Hang Yang, Wen-Juan Yang, Bing Hu
    World Journal of Gastrointestinal Oncology.2022; 14(2): 396.     CrossRef
  • COX-2 strengthens the effects of acid and bile salts on human esophageal cells and Barrett esophageal cells
    Shen Jiangang, Kang Nayoung, Wang Hongfang, Li Junda, Chen Li, Bai Xuefeng, Li Mingsong
    BMC Molecular and Cell Biology.2022;[Epub]     CrossRef
  • Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study
    Pascale Tomasini, Fabrice Barlesi, Sophie Gilles, Isabelle Nanni-Metellus, Riccardo Soffietti, Emilie Denicolai, Eric Pellegrino, Emilie Bialecki, L’Houcine Ouafik, Philippe Metellus
    Oncotarget.2020; 11(50): 4648.     CrossRef
  • A High Ki67/BCL2 Index Could Predict Lower Disease-Free and Overall Survival in Intestinal-Type Gastric Cancer
    Kyueng-Whan Min, Dong-Hoon Kim, Byoung Kwan Son, Dong Hyun Kim, Eun-Kyung Kim, Jinwon Seo, Sang Bong Ahn, Yun Ju Jo, Young Sook Park, Junghoon Ha
    European Surgical Research.2017; 58(3-4): 158.     CrossRef

J Pathol Transl Med : Journal of Pathology and Translational Medicine
TOP